Your browser doesn't support javascript.
loading
Novel potential predictive markers of sunitinib outcomes in long-term responders versus primary refractory patients with metastatic clear-cell renal cell carcinoma.
Puente, Javier; Laínez, Nuria; Dueñas, Marta; Méndez-Vidal, María José; Esteban, Emilio; Castellano, Daniel; Martinez-Fernández, Mónica; Basterretxea, Laura; Juan-Fita, María José; Antón, Luis; León, Luis; Lambea, Julio; Pérez-Valderrama, Begoña; Vázquez, Sergio; Suarez, Cristina; Del Muro, Xavier Garcia; Gallardo, Enrique; Maroto, José Pablo; Samaniego, M Luz; Suárez-Paniagua, Beatriz; Sanz, Julián; Paramio, Jesús M.
Afiliação
  • Puente J; Medical Oncology Department, Instituto de Investigación Biomédica, Hospital Clínico Universitario San Carlos, Madrid, Spain.
  • Laínez N; Medical Oncology Department, Complejo Hospitalario de Navarra, Pamplona, Spain.
  • Dueñas M; Molecular Oncology Unit CIEMAT and Instituto Investigación Biomédica, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Méndez-Vidal MJ; CIBERONC, Spain.
  • Esteban E; Medical Oncology Department, Hospital Universitario Reina Sofía, Córdoba, Spain.
  • Castellano D; Medical Oncology Department, Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Martinez-Fernández M; CIBERONC, Spain.
  • Basterretxea L; Medical Oncology Department, and Instituto Investigación Biomédica, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Juan-Fita MJ; Molecular Oncology Unit CIEMAT and Instituto Investigación Biomédica, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Antón L; CIBERONC, Spain.
  • León L; Medical Oncology Department, Hospital Donostia, Donostia, Spain.
  • Lambea J; Medical Oncology Department, Instituto Valenciano de Oncología, Valencia, Spain.
  • Pérez-Valderrama B; Medical Oncology Department, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain.
  • Vázquez S; Promoción e Planificación da Investigación Sanitaria, Axencia de Coñecemento en Saúde, Santiago de Compostela, Spain.
  • Suarez C; Medical Oncology Department, Hospital Clínico de Zaragoza, Zaragoza, Spain.
  • Del Muro XG; Medical Oncology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
  • Gallardo E; Medical Oncology Department, Hospital Universitario Lucus Augusti, Lugo, Spain.
  • Maroto JP; Vall d'Hebron Institute of Oncology, Hospital Universitari Vall d' Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Samaniego ML; Medical Oncology Department, Institut Català d'Oncologia, Hospital Duran i Reynals, L'Hospitalet, Barcelona, Spain.
  • Suárez-Paniagua B; Medical Oncology Department, Hospital Universitari Parc Taulí, Sabadell, Spain.
  • Sanz J; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Paramio JM; Statistical Department, Trial Form Support TFS people, Madrid, Spain.
Oncotarget ; 8(18): 30410-30421, 2017 May 02.
Article em En | MEDLINE | ID: mdl-28423742
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Biomarcadores Tumorais Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Biomarcadores Tumorais Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Espanha